LYELL Trademark

Trademark Overview

On Thursday, December 13, 2018, a trademark application was filed for LYELL with the United States Patent and Trademark Office. The USPTO has given the LYELL trademark a serial number of 88228691. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by Lyell Immunopharma, Inc.. The LYELL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and drugs for the treatment of cancer; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes

Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; medical and scientific research
lyell

General Information

Serial Number88228691
Word MarkLYELL
Filing DateThursday, December 13, 2018
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7207833
Registration DateTuesday, October 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and drugs for the treatment of cancer; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes
Goods and ServicesPharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; medical and scientific research

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 5, 2019
Primary Code005
First Use Anywhere DateThursday, January 5, 2023
First Use In Commerce DateThursday, January 5, 2023
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 5, 2019
Primary Code042
First Use Anywhere DateThursday, September 19, 2019
First Use In Commerce DateThursday, September 19, 2019

Trademark Owner History

Party NameLyell Immunopharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameLyell Immunopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameLyell Immunopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events

Event DateEvent Description
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, September 28, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 27, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, August 18, 2023USE AMENDMENT FILED
Friday, August 18, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, February 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2023SOU EXTENSION 5 GRANTED
Friday, January 27, 2023SOU EXTENSION 5 FILED
Monday, February 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 27, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 28, 2022SOU EXTENSION 4 GRANTED
Thursday, July 28, 2022SOU EXTENSION 4 FILED
Thursday, July 28, 2022SOU TEAS EXTENSION RECEIVED
Friday, January 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 19, 2022SOU EXTENSION 3 GRANTED
Wednesday, January 19, 2022SOU EXTENSION 3 FILED
Wednesday, January 19, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 5, 2021SOU EXTENSION 2 GRANTED
Thursday, August 5, 2021SOU EXTENSION 2 FILED
Thursday, August 5, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 31, 2020SOU EXTENSION 1 GRANTED
Thursday, December 31, 2020SOU EXTENSION 1 FILED
Thursday, December 31, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 12, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, April 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 24, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 15, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 15, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 15, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 15, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 15, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 31, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 31, 2019FINAL REFUSAL E-MAILED
Thursday, October 31, 2019FINAL REFUSAL WRITTEN
Tuesday, October 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 7, 2019ASSIGNED TO LIE
Tuesday, October 1, 2019NOTICE OF REVIVAL - E-MAILED
Tuesday, October 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 1, 2019PETITION TO REVIVE-GRANTED
Tuesday, October 1, 2019TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 19, 2019NON-FINAL ACTION E-MAILED
Tuesday, March 19, 2019NON-FINAL ACTION WRITTEN
Tuesday, March 12, 2019ASSIGNED TO EXAMINER
Saturday, January 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 17, 2018NEW APPLICATION ENTERED

Related Keywords

lyell pharmaceutical preparations development drugs medical purposes clinical research therapy scientific